Last updated 2026-11-09
Portfolio
3
in our dataset
Rounds participated
3
Rounds led
3
Rounds' value
$28.0M
total disclosed, rounds participated
Stages
Initial Revenues, R&D, Clinical Trials, Phase II, Phase III
About
Guangzhou-Israel Biotechnology Fund (GIBF) is a venture capital firm established in 2016 in partnership with the Government of Guangzhou, China. It is uniquely managed and controlled by its Israeli partners, making it the only Chinese fund under foreign management licensed to make private equity investments in China by the Chinese Securities and Exchange Commission. GIBF focuses on investing in Israeli and European life science and biotechnology companies, helping them establish operations and commercialize technologies in the Chinese market through joint ventures.
Portfolio · 3
Biond Biologics
A clinical-stage biopharmaceutical company developing first-in-class immunotherapies for cancer and immune-mediated diseases.
Nectin Therapeutics
Nectin Therapeutics is a biotechnology company developing next-generation immune-oncology (IO) and antibody-drug conjugate (ADC) therapies for cancer patients.
4Oncology
In stealth mode, developing medical devices in the oncology sector.
Q&A
- What is the primary focus of Guangzhou-Israel Biotechnology Fund (GIBF)?
- Guangzhou-Israel Biotechnology Fund (GIBF) primarily focuses on investing in Israeli and European life science and biotechnology companies, assisting them in establishing operations and commercializing technologies in the Chinese market.
- When was Guangzhou-Israel Biotechnology Fund (GIBF) established?
- Guangzhou-Israel Biotechnology Fund (GIBF) was established in March 2016.
- What is the total AUM of Guangzhou-Israel Biotechnology Fund (GIBF)?
- Guangzhou-Israel Biotechnology Fund (GIBF) has a total AUM of $400 million USD.
- Which funds has Guangzhou-Israel Biotechnology Fund (GIBF) raised?
- Guangzhou-Israel Biotechnology Fund (GIBF) raised GIBF 1 in 2016 with $100 million USD and GIBF 2 in 2021 with $300 million USD.
- What is the typical check size for Guangzhou-Israel Biotechnology Fund (GIBF) investments?
- Guangzhou-Israel Biotechnology Fund (GIBF) typically invests between $3 million and $20 million USD per company.
- What is unique about GIBF's management structure?
- Guangzhou-Israel Biotechnology Fund (GIBF) is uniquely managed and controlled by its Israeli partners, making it the only Chinese fund under foreign management licensed to make private equity investments in China by the Chinese Securities and Exchange Commission.
- Who are some of the founding partners at Guangzhou-Israel Biotechnology Fund (GIBF)?
- Founding partners at Guangzhou-Israel Biotechnology Fund (GIBF) include Dr. Yehoshua (Shuki) Gleitman, Prof. Shlomo Noy, and Avner Lushi.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | gibf-bio.com |
|---|
Identifiers & details
| Founded | 2016-3 |
|---|